Clinical Outcomes Associated With Escherichia coli Infections in Adults With Cystic Fibrosis: A Cohort Study

BACKGROUND: Analysis of “emerging” pathogens in cystic fibrosis (CF) lung disease has focused on unique pathogens that are rare in other human diseases or are drug resistant. Escherichia coli is recovered in the sputum of up to 25% of patients with CF, yet little is known about the epidemiology or c...

Descripción completa

Detalles Bibliográficos
Autores principales: Edwards, B D, Somayaji, R, Greysson-Wong, J, Izydorczyk, C, Waddell, B, Storey, D G, Rabin, H R, Surette, M G, Parkins, M D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966422/
https://www.ncbi.nlm.nih.gov/pubmed/31976352
http://dx.doi.org/10.1093/ofid/ofz476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966422/
https://www.ncbi.nlm.nih.gov/pubmed/31976352
http://dx.doi.org/10.1093/ofid/ofz476

Ejemplares similares